Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Current Assets (2020 - 2025)

PROCEPT BioRobotics has reported Current Assets over the past 6 years, most recently at $450.4 million for Q4 2025.

  • Quarterly results put Current Assets at $450.4 million for Q4 2025, down 6.53% from a year ago — trailing twelve months through Dec 2025 was $450.4 million (down 6.53% YoY), and the annual figure for FY2025 was $450.4 million, down 6.53%.
  • Current Assets for Q4 2025 was $450.4 million at PROCEPT BioRobotics, down from $454.8 million in the prior quarter.
  • Over the last five years, Current Assets for PRCT hit a ceiling of $481.8 million in Q4 2024 and a floor of $230.0 million in Q2 2023.
  • Median Current Assets over the past 5 years was $327.7 million (2021), compared with a mean of $350.7 million.
  • Biggest five-year swings in Current Assets: skyrocketed 195.83% in 2021 and later fell 22.9% in 2023.
  • PROCEPT BioRobotics' Current Assets stood at $326.2 million in 2021, then decreased by 16.42% to $272.6 million in 2022, then grew by 28.59% to $350.6 million in 2023, then surged by 37.45% to $481.8 million in 2024, then fell by 6.53% to $450.4 million in 2025.
  • The last three reported values for Current Assets were $450.4 million (Q4 2025), $454.8 million (Q3 2025), and $458.1 million (Q2 2025) per Business Quant data.